Xuefeng Li

Soyasaponins Can Blunt Inflammation by Inhibiting the Reactive Oxygen Species-Mediated Activation of PI3K/Akt/NF-kB Pathway

Longying Zha, Jiading Chen, Suxia Sun et al. · PLoS ONE · 2014 · 148 citations · Full text

Pge2 Production, Lipid Peroxidation, Immunology +22

Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial

Dalong Zhu, Jianhua Ma, Jiao’e Zeng et al. · Nature Medicine · 2022 · 87 citations · Full text

Metabolic Syndrome, Diabetes Management, Placebo-controlled Phase 3 +8

Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial

Wenying Yang, Dalong Zhu, Shenglian Gan et al. · Nature Medicine · 2022 · 73 citations · Full text

Metabolic Syndrome, Adverse Events, Diabetes Management +10

Predictors of Clinical and Endoscopic Findings in Differentiating Crohn’s Disease from Intestinal Tuberculosis

Xuefeng Li, Xiaowei Liu, Yi-You Zou et al. · Digestive Diseases and Sciences · 2010 · 64 citations

Endoscopic Findings, Pulmonary Tuberculosis, Intestinal Tuberculosis +9

Increased circulating myostatin in patients with type 2 diabetes mellitus

Fang Wang, Yonggan Liao, Xuefeng Li et al. · Journal of Huazhong University of Science and Technology [Medical Sciences] · 2012 · 40 citations

Metabolic Syndrome, Autoimmune Disease, Physiology +7